Abstract

Hepatitis B virus (HBV) is a para-retrovirus that reverse transcribes its pregenomic RNA into relaxed circular DNA inside viral nucleocapsids. The number of HBV genomes produced in vitro is typically quantified using commercial silica-membrane-based nucleic acid purification kits to isolate total DNA followed by HBV-specific quantitative PCR (qPCR). However, despite the convenience of commercial kits, this procedure is costly and time-consuming due to multiple centrifugation steps, which produce unnecessary waste. Here, we report a rapid, cost-effective, and environmentally friendly total DNA preparation method. The assay is based on the simple incubation of detergent and proteinase K with cells or cell-free supernatants to permeabilize cells and disrupt viral particles. After heat inactivation and subsequent centrifugation to clear the lysates, DNA samples are directly subjected to qPCR to quantify HBV genomes. As a proof of concept, the assay was developed in 12-well plates to assess intra- and extracellular HBV genome equivalents (GEqs) of stably viral-replicating cell lines (e.g., HepAD38) and HBV-infected HepG2-NTCP cells, both treated with lamivudine (LMV), an HBV replication inhibitor. Viral DNA was also prepared from the serum of patients chronically infected with HBV. To validate the assay, a representative commercial DNA isolation kit was used side-by-side to isolate intra- and extracellular HBV DNA. Both methods yielded comparable amounts of HBV GEqs with comparable LMV 50% efficient concentration (EC50) values. The assay was subsequently adapted to 96- and 384-well microtiter plates using HepAD38 cells. The EC50 values were comparable to those obtained in 12-well plates. In addition, the calculated coefficient of variation, Z’ values, and assay window demonstrated high reproducibility and quality. We devised a novel, robust, reproducible, high-throughput microtiter plate DNA preparation method suitable for quantifying HBV GEqs by qPCR analysis. This strategy enables rapid and convenient quantitative analysis of multiple viral DNA samples in parallel to investigate intracellular HBV replication and the secretion of DNA-containing viral particles.

Highlights

  • Hepatitis B virus (HBV) is one of the most common viral infections affecting humans worldwide.Currently, 3.5% of the world’s population is chronically infected with the virus and at risk of developing life-threatening liver diseases [1]

  • In epidemiologic studies, HBV relaxed circular DNA (rcDNA) sequences are informative regarding the distribution of different HBV genotypes and subgenotypes

  • HepAD38 cells were kindly provided by Dr Christoph Seeger (Fox Chase Center; Philadelphia, PA, USA) and cultured in Dulbecco’s Modified Eagle Medium (DMEM)/F12 medium supplemented with 10% fetal bovine serum (FBS), 50 U/mL penicillin-streptomycin (P/S), and 400 μg/mL geneticin

Read more

Summary

Introduction

3.5% of the world’s population is chronically infected with the virus and at risk of developing life-threatening liver diseases [1]. HBV is the prototype member of the family Hepadnaviridae. This small, enveloped, DNA-containing virus replicates inside viral capsids via reverse transcription of its pregenomic RNA (pgRNA), mediated by viral reverse transcriptase (RT), into an approximately 3.2-kb, partially double-stranded, relaxed circular DNA (rcDNA) genome [2]. RcDNA is one of the most commonly used biomarkers in hospitals and laboratories (e.g., to determine viral infection status, evaluate viral fitness and antiviral efficacy of drugs and inhibitors, and guide treatment decisions) [3]. In the case of treatment complications, sequencing of the HBV rcDNA can provide insights into the potential development of resistance mutations [4]. In epidemiologic studies, HBV rcDNA sequences are informative regarding the distribution of different HBV genotypes and subgenotypes

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call